Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
In the fast-paced world of translational oncology, pharmaceutical developers face a relentless challenge: how to move programs from the laboratory to …
Read more
At AACR 2026, one message became clear: oncology drug development is entering a new era defined by smarter decision-making, integrated platforms, and …
Read more
Originally posted in Drug Discovery News on January 26, 2026, by Marianne Baillargeon Integrating patient-derived xenografts and organoids can help re…
Read more
